Jacksonville Bncp (JXSB) 29.42 $JXSB Jacksonville

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Jacksonville Bncp (JXSB) 29.42 $JXSB

Jacksonville Bancorp, Inc. (JXSB) Declares Dividend
GlobeNewswire - Tue Jun 21, 2:29PM CDT
Andrew F. Applebee, Chairman of Jacksonville Bancorp, Inc. (NASDAQ:JXSB), (the "Bancorp" today announced that the Bancorp has declared our quarterly cash dividend of $0.10 per share on the Bancorp's common stock. The dividend will be payable to stockholders of record as of July 1, 2016, and will be paid on July 12, 2016.
JXSB: 29.42 (-0.03)

Jacksonville Bancorp, Inc. Announces First Quarter 2016 Earnings
GlobeNewswire - Fri Apr 08, 9:44AM CDT
Jacksonville Bancorp, Inc. (NASDAQ:JXSB) reported unaudited net income for the three months ended March 31, 2016, of $827,000, or $0.47 per share of common stock, basic, and $0.46 per common share, diluted, compared to net income of $786,000, or $0.44 per share of common stock, basic and diluted, for the three months ended March 31, 2015. Basic and diluted average shares outstanding at March 31, 2016 were 1,770,917 and 1,788,972, respectively. Basic and diluted average shares outstanding at March 31, 2015 were 1,775,287 and 1,792,367, respectively.
JXSB: 29.42 (-0.03)

Jacksonville Bancorp, Inc. Announces Financial Results at and for the Three Months and Year Ended December 31, 2015
GlobeNewswire - Tue Jan 12, 8:36AM CST
Jacksonville Bancorp, Inc. (NASDAQ:JXSB) reported unaudited net income for the three months ended December 31, 2015, of $704,000, or $0.40 per basic common share and $0.39 per diluted common share compared to net income of $652,000, or $0.37 per basic common share and $0.36 per diluted common share for the three months ended December 31, 2014. Net income for the quarter ended December 31, 2015 increased $52,000 compared to the quarter ended December 31, 2014, due to increases of $87,000 in net interest income and $37,000 in noninterest income and a decrease of $120,000 in the provision for loan losses, partially offset by increases of $157,000 in noninterest expense and $35,000 in income taxes.
JXSB: 29.42 (-0.03)

Jacksonville Bancorp, Inc. (JXSB) Declares Quarterly And Special Dividends
PR Newswire - Tue Dec 08, 2:48PM CST
Andrew F. Applebee, Chairman of Jacksonville Bancorp, Inc. (the "Bancorp" today announced that the Bancorp has declared a cash dividend of $.08 per share on the Bancorp's common stock for the fiscal quarter ending December 31, 2015. The dividend will be payable to stockholders of record as of December 23, 2015, and will be paid on January 6, 2016.
JXSB: 29.42 (-0.03)

Jacksonville Bancorp, Inc. Announces Quarterly Earnings
PR Newswire - Fri Oct 09, 12:07PM CDT
Jacksonville Bancorp, Inc. (NASDAQ Capital Market - JXSB) reported unaudited net income for the three months ended September 30, 2015, of $699,000, or $0.40 per share of common stock, basic, and $0.39 per common share, diluted, compared to net income of $856,000, or $0.48 per share of common stock, basic, and $0.47 per common share, diluted, for the three months ended September 30, 2014. The Company reported unaudited net income of $2,322,000, or $1.31 per share of common stock, basic and $1.30 per common share, diluted, for the nine months ended September 30, 2015, compared to net income of $2,321,000, or $1.29 per common share, basic and diluted, for the nine months ended September 30, 2014. Basic per share information for the three and nine months ended September 30, 2015, is based upon 1,765,873 and 1,771,810 average shares outstanding, respectively, compared to 1,795,252 and 1,795,007 average shares outstanding, respectively, during the same periods in 2014.
JXSB: 29.42 (-0.03)

Jacksonville Bancorp announces dividend of USD0.08 per share for fiscal quarter
M2 - Wed Sep 16, 5:35AM CDT
Chairman Andrew F. Applebee of Jacksonville Bancorp Inc (NASDAQ:JXSB) announced on Tuesday that the company will pay a cash dividend of USD0.08 per share on its common stock for the fiscal quarter ending 30 September 2015.
JXSB: 29.42 (-0.03)

Jacksonville Bancorp, Inc. Announces Financial Results At And For The Three And Six Months Ended June 30, 2015
PR Newswire - Wed Jul 08, 11:55AM CDT
Jacksonville Bancorp, Inc. (NASDAQ Capital Market - JXSB) reported unaudited net income for the three months ended June 30, 2015, of $836,000, or $0.47 per share of common stock, basic and diluted, compared to net income of $625,000, or $0.35 per share of common stock, basic and diluted, for the three months ended June 30, 2014. The Company reported unaudited net income of $1,623,000, or $0.91 per share of common stock, basic and diluted, for the six months ended June 30, 2015, compared to net income of $1,465,000, or $0.82 per share of common stock, basic, and $0.81 per share, diluted, for the six months ended June 30, 2014. Per share information for the three and six months ended June 30, 2015, is based upon 1,774,375 and 1,774,828 average shares outstanding, respectively, compared to the three and six months ended June 30, 2014, which was based upon 1,795,133 and 1,794,883 average shares outstanding, respectively.
JXSB: 29.42 (-0.03)

Jacksonville Bancorp, Inc. Announces Financial Results At And For The Three Months And Year Ended December 31, 2014
PR Newswire - Fri Jan 09, 8:56AM CST
Jacksonville Bancorp, Inc. (NASDAQ Capital Market - JXSB) reported unaudited net income for the three months ended December 31, 2014, of $652,000, or $0.37 per basic common share and $0.36 per diluted common share compared to net income of $655,000, or $0.36 per basic and diluted common share for the three months ended December 31, 2013. Net income for the quarter ended December 31, 2014 decreased $3,000 compared to the quarter ended December 31, 2013, due to a decrease of $140,000 in net interest income and an increase of $20,000 in the provision for loan losses, partially offset by an increase of $31,000 in noninterest income and decreases of $102,000 in noninterest expense and $24,000 in income taxes.
JXSB: 29.42 (-0.03)

Jacksonville Bancorp announces dividend of USD0.08 per share
M2 - Wed Dec 10, 6:07AM CST
Chairman Andrew F. Applebee of Jacksonville Bancorp Inc (NASDAQ:JXSB), the parent company of Jacksonville Savings Bank, reported on Tuesday that the company will pay a cash dividend of USD0.08 per share on its common stock, for the fiscal quarter ending 31 December 2014.
JXSB: 29.42 (-0.03)

Jacksonville Bancorp, Inc. Declares Dividend
PR Newswire - Tue Dec 09, 2:32PM CST
Andrew F. Applebee, Chairman of Jacksonville Bancorp, Inc. (the "Bancorp" (NASDAQ: JXSB) today announced that the Bancorp has declared a cash dividend of $.08 per share on the Bancorp's common stock for the fiscal quarter ending December 31, 2014. The dividend will be payable to stockholders of record as of December 19, 2014, and will be paid on January 5, 2015.
JXSB: 29.42 (-0.03)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ON1 Photo RAW 2027: New AI Tools, Better Processing

Updated Category News Views 50

Aiming for the Photography Crown ON1 isn't just tinkering on the fringes with their new Photo RAW 2027 release—they're diving headfirst into the deep end, aiming to outdo giants in the RAW processing world. I've seen my share of software updates that don't move the needle, but this one's packed to the gills with updates that photographers have been clamoring for. What's...

Continue Reading
China's Innovation Surge: Game Changer for Global Markets

Updated Category News Views 235

The Bold Shift in China's Economic Landscape Well, here's the scoop: China isn't just the world's assembly line anymore; it's gearing up to be a top-tier innovation hub. On the surface, might seem like another geopolitical spiel, but dig a little and you'll find it's a serious shake-up for global markets. We're talking about more than just products rolling out of...

Continue Reading
Jeep Wrangler Scrambler SRT: A Bold Off-Road Rebirth

Updated Category News Views 0

A New Legend in the Making Who would've thought we'd see the day when an SRT badge graced a Jeep Wrangler with such audacity? This ain't your typical Wrangler—they’ve slapped a bit of that CJ-8 throwback swagger, and given it the full-on SRT treatment. It's a mad machine, barreling into the future with one foot firmly planted in its legendary past. You ask any...

Continue Reading
Florida Homebuyers: Navigating Flood Zone Risks Smartly

Updated Category News Views 92

Florida Properties: The Buried Risk in Flood Zones If you’re dreaming of palm trees and sandy beaches, don't let flood zones turn that dream into a nightmare. It’s not all sunshine and rainbows when it comes to buying real estate in Florida, as it turns out—flood zones are lurking, and the devil's in the details. Understanding FEMA Flood Maps First off, these FEMA...

Continue Reading
ACA 2027 Enrollment: New Rules Aim to Simplify Coverage

Updated Category News Views 61

Navigating New Waters in 2027 ACA Open Enrollment If you're one of those folks who likes to wait until the last minute, the ACA's got a wake-up call for you this year. The 2027 open enrollment period started on November 1, 2026, with some pretty notable changes. The deadline for coverage beginning January 1, 2027, is December 15, so don't take a nap on this one, alright?...

Continue Reading
Beyon Expands Green Data Centres to Three Facilities

Updated Category News Views 37

Blazing Solar Trails in the Digital Landscape Lend an ear, folks, because Beyon's latest leap in the world of renewable energy isn't just another 'look how green we are' maneuver. Announced during Gateway Gulf 2026, this venture is all about serious numbers and even more serious energy chops. Beyon's on course to power a third data center entirely through solar energy,...

Continue Reading
Lazard Closes Deal with Campbell, Launches Lazard CL

Updated Category News Views 59

Talk about pulling a rabbit out of the hat! Lazard has just solidified its position in the private capital advisory game with the closure of its acquisition of Campbell Lutyens. They’re now rolling out Lazard CL, merging muscle across different strategies and diversifying those good ol’ revenue streams. It’s a peppy move from Lazard—not just for the cold hard...

Continue Reading
Xylitol: A Game Changer in Kids' Oral Care Battle

Updated Category News Views 91

Candy Challenges: Embracing Sweet Joys Responsibly Think you're done with Halloween? Nope. Welcome to the endless candy seasons when every festivity seems like an outlet for sugar overload—with parents caught between letting kids enjoy and guarding their teeth. Now, with Spry's recent push around xylitol, there's an option that might just mean an easier peace between...

Continue Reading
Military Medical Minds to Converge at MTEC Event in 2027

Updated Category News Views 72

Ever wonder where the cutting edge of military medicine takes shape? On February 16-17, 2027, Washington, DC becomes the epicenter for just that, as the Medical Technology Enterprise Consortium (MTEC) rolls out its 11th Annual Membership Meeting. A gathering of who's who in the world of military medical innovation, this event is like a high-stakes cocktail of science,...

Continue Reading
Sirolimus-Coated Balloon Shows Promise in TRANSFORM II

Updated Category News Views 96

Breaking Down the TRANSFORM II Trial Innovation never rests, folks, especially when it comes to treating coronary artery disease. Right on cue, the TRANSFORM II trial's results have hit the airwaves, marking a significant milestone with its implant-free MagicTouch Sirolimus-Coated Balloon (SCB) strategy. Getting the Lay of the Land This wasn't just some backyard...

Continue Reading

Top 5 Most Recently Viewed Articles

ATYR Stock Investors: Important Class Action Update

Updated Category News Views 139

Key Information for ATYR Pharma Shareholders ATYR Pharma, Inc. has recently faced significant challenges that have caught the attention of its shareholders. Investors who have purchased shares of ATYR during the specified class period are encouraged to stay informed about the ongoing legal developments. Engaging with The Gross Law Firm can provide shareholders with the...

Continue Reading
Zymeworks Stock Target Steady After Positive Trial Results

Updated Category News Views 89

Zymeworks Keeps Stock Rating Steady After ESMO 2024 Results Zymeworks Inc. (NASDAQ: ZYME) has maintained its stock rating and price target after revealing encouraging results from its recent cancer treatment clinical trials at a significant medical conference. The ratings firm H.C. Wainwright has reiterated a Neutral rating and set a price target of $10.00 per share...

Continue Reading
Exploring New Opportunities in Convertible Bonds with BMAX ETF

Updated Category News Views 253

Introduction to the New ETF A recently introduced exchange-traded fund (ETF), known as the REX Bitcoin Corporate Treasury Convertible Bond ETF (BMAX), is gaining attention for its focus on convertible bonds from companies that have Bitcoin included in their financial strategies. This ETF began trading recently and represents a growing trend in the investment landscape....

Continue Reading
iBio Secures Strategic Investments to Propel Biotech Advancements

Updated Category News Views 140

iBio's Strategic Investment Announcement iBio, Inc. (NYSE: IBIO), a pioneer in AI-driven antibody immunotherapies, has made an impactful stride in its mission, announcing the successful closure of a private investment offering totaling over $650,000 from its Board of Directors and corporate officers. This investment is a significant vote of confidence in iBio's strategy...

Continue Reading
Simulmedia Welcomes Jonathan Steuer as Chief Scientist

Updated Category News Views 111

Simulmedia Appoints Jonathan Steuer as Chief Scientist Simulmedia, a leader in cross-channel TV and connected TV (CTV) advertising, is thrilled to announce a significant addition to its executive team. Jonathan Steuer, a prominent figure in media research and data science, has been appointed as the Chief Scientist. With a remarkable background as a scientist and...

Continue Reading